You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: February 21, 2026

GEMCITABINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Gemcitabine patents expire, and when can generic versions of Gemcitabine launch?

Gemcitabine is a drug marketed by Accord Hlthcare, Actavis Inc, Actavis Totowa, Am Regent, Apotex, Dr Reddys Labs Ltd, Emcure Pharms Ltd, Fresenius Kabi Usa, Gland, Hameln Rds Gmbh, Hikma, Hikma Intl Pharms, Hospira, Hospira Inc, Jiangsu Hansoh Pharm, Meitheal, Mylan Labs Ltd, Novast Labs, Pharmobedient, Sagent Pharms, Sagent Pharms Inc, Shilpa, Sun Pharm, Teva Pharms, and Teyro Labs. and is included in thirty NDAs.

The generic ingredient in GEMCITABINE is gemcitabine hydrochloride. There are thirty drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the gemcitabine hydrochloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for GEMCITABINE?
  • What are the global sales for GEMCITABINE?
  • What is Average Wholesale Price for GEMCITABINE?
Summary for GEMCITABINE
US Patents:0
Applicants:25
NDAs:30
Drug Prices: Drug price information for GEMCITABINE
What excipients (inactive ingredients) are in GEMCITABINE?GEMCITABINE excipients list
DailyMed Link:GEMCITABINE at DailyMed
Drug patent expirations by year for GEMCITABINE
Drug Prices for GEMCITABINE

See drug prices for GEMCITABINE

US Patents and Regulatory Information for GEMCITABINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare GEMCITABINE HYDROCHLORIDE gemcitabine hydrochloride SOLUTION;INTRAVENOUS 209604-001 Aug 3, 2017 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Meitheal GEMCITABINE HYDROCHLORIDE gemcitabine hydrochloride INJECTABLE;INJECTION 212129-002 Dec 11, 2020 AP RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Hikma Intl Pharms GEMCITABINE HYDROCHLORIDE gemcitabine hydrochloride INJECTABLE;INJECTION 206617-001 Jun 25, 2021 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Novast Labs GEMCITABINE HYDROCHLORIDE gemcitabine hydrochloride INJECTABLE;INJECTION 210383-001 Feb 14, 2019 AP RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Shilpa GEMCITABINE HYDROCHLORIDE gemcitabine hydrochloride INJECTABLE;INJECTION 210991-003 Oct 4, 2019 AP RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Mylan Labs Ltd GEMCITABINE HYDROCHLORIDE gemcitabine hydrochloride INJECTABLE;INJECTION 205242-003 Dec 6, 2017 AP RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.